Valiant Organics Limited (VALIANTORG) — Board Meeting | 12 August 2026(3 announcements)

· NSE 🟡 Notable Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
1 Board Meeting 🟡 Notable Neutral 📄 PDF
📢 Key Event
NRC approved 18,000 employee stock options at Rs.10 exercise price under 2022 ESOP Scheme
🔄 What Changed
18,000 new stock options granted at Rs.10 exercise price
🔮 What's Next
Options exercisable within 3 years from vesting; no future grant details disclosed
💡 Investor Takeaway
This creates potential future dilution if options are exercised, but no immediate financial impact.

On August 12, 2026, Valiant Organics' Nomination and Remuneration Committee approved the grant of 18,000 employee stock options under the 2022 ESOP Scheme at a Rs.10 exercise price per option, enabling employees to purchase one equity share each upon vesting within three years, with no dilution or earnings impact yet as options remain unexercised.

2 Board Meeting 🟡 Notable Neutral 📄 PDF
📢 Key Event
Board approved Q1 FY27 results, reappointed MD for 2027-2030, and proposed office relocation to Tarapur and Vikhroli.
🔄 What Changed
Re-appointment of MD for 3 years; proposed shift of registered office to Tarapur and corporate office to Vikhroli.
🔮 What's Next
Re-appointment of MD until 2030; office relocation pending shareholder approval at AGM.
💡 Investor Takeaway
The MD's re-appointment ensures leadership continuity, but office shifts require shareholder approval and may impact operational logistics.

Valiant Organics announced the outcome of its August 12, 2026 board meeting, approving unaudited financial results for Q1 FY27, reappointing Managing Director Sathiababu K. Kallada for 2027-2030, and seeking shareholder approval to shift its registered office to Tarapur and corporate office to Vikhroli. The meeting ran from 12:35 PM to 3:50 PM IST.

3 Board Meeting 🟡 Notable Neutral 📄 PDF
📢 Key Event
Board approved Q1 FY2026 financial results and MD re-appointment
🔄 What Changed
Approved unaudited financial results for Q1 FY2026; re-appointed MD for 3 years; proposed registered office shift
🔮 What's Next
Re-appointment of MD effective May 24, 2027 to May 23, 2030, subject to shareholder approval at AGM
💡 Investor Takeaway
The MD's re-appointment ensures leadership continuity, but the new term starts only in 2027, creating a leadership gap until then.

The Board of Valiant Organics Limited approved unaudited standalone and consolidated financial results for Q1 FY2026 ending June 30, 2026, along with the re-appointment of Managing Director Shri Sathiababu K. Kallada for a three-year term from May 24, 2027 to May 23, 2030, subject to shareholder approval at the upcoming AGM, and proposed shifting the registered office to Tarapur, Maharashtra.

About Valiant Organics Limited (VALIANTORG)

Chemicals · Chemicals · Listed on NSE

Market Cap: ₹853.79 Cr P/E: 15.7 ROE: 7.5% ROCE: 8.7%

View full VALIANTORG stock details →

📡 Get AI alerts when VALIANTORG files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track VALIANTORG — Free

📊 More VALIANTORG filings

See all VALIANTORG filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when VALIANTORG files new disclosures

Track VALIANTORG filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track VALIANTORG — Free

Free account · 2 AI queries/day